Taken together, the results from the BMECs infection assays provide evidence of an additive effect of both ΔhemB and ΔvraG mutations for the attenuation of the wild-type strain; the vraG mutation mainly lowering the intracellular bacterial load and the hemB mutation creating the SCV phenotype that increases MAC-T cells viability. The gene discussed is F9; the disease is infection.